RNA therapeutics

NANTONG, China, July 29, 2026 Ractigen Therapeutics has successfully closed a financing round exceeding $31 million (over RMB 200...

SAN RAFAEL, Calif. & SAN DIEGO, July 27, 2026 BioMarin Pharmaceutical Inc. and the n-Lorem Foundation have announced a...

CAMBRIDGE, Mass., July 27, 2026 CAMP4 Therapeutics announced that it has received regulatory clearance from Australia’s Therapeutic Goods Administration...

VALENCIA, Spain, July 23, 2026 ARTHEx Biotech has announced the publication of groundbreaking preclinical data demonstrating that its investigational...

SAN DIEGO, Calif., July 15, 2026 Primrose Bio, Inc. has secured a $2 million Direct-to-Phase II Small Business Innovation...

SAN DIEGO, Calif., July 14, 2026 Atrium Therapeutics has achieved an important regulatory milestone after the U.S. Food and...

CAMBRIDGE, United Kingdom, July 9, 2026 AstraZeneca and Ionis Pharmaceuticals have announced results from the Phase III CARDIO-TTRansform trial...

ROCKVILLE, Maryland, July 4, 2026 Immunomic Therapeutics Inc. (ITI), a clinical-stage biotechnology company and subsidiary of HLB, has announced...

HONG KONG, July 2, 2026 CSPC Pharmaceutical Group Limited has announced a strategic collaboration, option and license agreement with...

SAN DIEGO, Calif., July 2, 2026 Arcturus Therapeutics Holdings Inc. announced a strategic collaboration with Thermo Fisher Scientific to...